Colon and Breast Cancer Diagnostics. Clinical Protocol Associated With Cancer of the Breast.
- Assess relapse locally or remotely using biomarkers collected from primary tumor and
blood samples from women with breast cancer during the first 2 years after diagnosis.
- Evaluate all relapses.
- Assess survival without relapse.
- Determine correlation between biomarkers and relapse.
OUTLINE: Primary tumor and blood samples collected during usual care of patients during the
first 2 years after diagnosis are analyzed for biomarkers useful in monitoring and
diagnosing breast cancer.
Local or remote relapse as assessed by biomarkers in tissue and blood samples collected during the first 2 years after diagnosis